Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds
More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
Patents for C07D - Heterocyclic compounds (10,420)
03/2001
03/27/2001US6207829 Cyclization of a corresponding pyrazole compound
03/27/2001US6207669 In treatment of cancer and psoriasis
03/27/2001US6207188 Omeprazole sodium salt
03/27/2001CA2091562C Indole derivatives useful in psychotherapeutics
03/22/2001WO2001019825A1 Pteridinones as kinase inhibitors
03/22/2001WO2001019812A1 Novel photochromic naphthopyrans
03/22/2001WO2000069862A3 Hemisynthetic method and intermediates thereof
03/22/2001CA2393896A1 Pteridinones as kinase inhibitors
03/21/2001EP1084109A1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors
03/21/2001CN1288458A Triazepinones, process for their prepn. and their therapeutic application
03/20/2001US6204286 8-(p-(pyrrolidinylalkoxy)phenyl)tetrahydronaphthols
03/15/2001WO2001017976A1 Bis-sulfonamides
03/15/2001US20010000038 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives
03/14/2001EP1082323A2 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
03/14/2001EP1082321A1 Heterocyclic derivatives which inhibit factor xa
03/14/2001EP1082304A1 NEW CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-p-TOLUOYLPYRROLE-2-ACETAMIDOACETIC ACID GUAIACYL ESTER (MED 15)
03/14/2001EP1082302A1 A vla-4 inhibitor: omepupa-v
03/13/2001US6201007 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
03/13/2001US6201002 Administering imidazole derivative to treat congestive heart failure and cardiovascular disorders
03/13/2001US6200981 For treating inflammatory diseases such as asthma, inflammatory bowel disease, psoriasis, rheumatoid arthritis, myocardial ischaemia, cystic fibrosis, arthereosclerosis, restenosis, peridontal disease, septic shock, osteoarthritis
03/08/2001WO2000076998B1 New bispidine compounds useful in the treatment of cardiac arrhythmias
03/07/2001EP1081155A2 N6 heterocyclic substituted adenosine derivatives
03/07/2001EP1081144A2 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems
03/07/2001EP1081143A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems
03/07/2001EP1080095A1 Modulators of protein tyrosine phosphatases (ptpases)
03/07/2001EP1080092A2 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
03/07/2001EP0625969B1 Arylalkoxyphenoxy-imidazoline compounds
03/07/2001CN1286251A Method for preparing 5-lipooxygenase inhibitor having changeable heterocycle system
03/07/2001CN1286250A Method for preparing 5-lipooxygenase inhibitor having changeable heterocycle system
03/06/2001US6197786 Anticholesterol agents
03/06/2001US6197781 Spray drying mixture of rapamycin suspension and carrier
03/01/2001WO2001014380A1 Isomeric fused pyrrolocarbazoles and isoindolones
03/01/2001WO2001014376A1 Novel spiro compounds
03/01/2001WO2001014353A1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
03/01/2001WO2001014330A2 Phenylpiperazines as serotonin reuptake inhibitors
02/2001
02/28/2001EP1078925A1 4-Phenylpiperidine compounds
02/28/2001EP1078637A2 Composition for the treatment and prevention of nicotine addiction containing a nicotine receptor agonist and an anti-depressant or anti-anxiety drug
02/28/2001EP1077984A1 2"-deoxy hygromycin derivatives
02/28/2001EP1077955A1 Method for producing isoxazoline-3-yl-acyl benzene
02/28/2001EP1077945A1 Isoquinolines as urokinase inhibitors
02/28/2001EP1077943A1 Heterocyclic inhibitors of p38
02/28/2001EP1077942A1 Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists
02/28/2001CN1285831A Substituted thiezolidinedione derivative, process for its preparation and pharmaceutical use
02/28/2001CA2317097A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems
02/28/2001CA2316748A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems
02/27/2001US6194583 Process for the preparation of a triazolinone herbicide
02/27/2001CA2317064A1 Pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal
02/22/2001WO2001012627A1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
02/22/2001WO2001012611A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
02/22/2001WO2001012607A2 Pharmaceutical compositions comprising 4-quinolones for treating cancers
02/22/2001WO2000071538A3 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
02/22/2001WO2000061122A3 Use of 6-methylmercaptopurine riboside in ophthalmologic compositions
02/22/2001CA2383268A1 Pyrazoloanthrone and derivatives thereof as jnk inhibitors and their compositions
02/22/2001CA2381975A1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
02/22/2001CA2381968A1 Pharmaceutical compositions comprising 4-quinolones for treating cancers
02/22/2001CA2381551A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
02/21/2001EP0975609A4 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
02/21/2001CN1284505A Azabicyclic compound
02/20/2001US6191287 Treating the taxane with a silyamide or a bissilylamide to form c10 silylated taxane
02/20/2001US6191140 Potassium channel modulators; muscle relaxants; controlling cell membranes
02/20/2001CA2223624C Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-.alpha.]pyridines
02/15/2001WO2000066584B1 1-AMINO TRIAZOLO¢4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV
02/14/2001EP1075483A2 Hygromycin a derivatives
02/14/2001CN1061977C Aryl substituted heterocycles
02/13/2001US6187792 Compounds with analgesic effect
02/13/2001US6187789 Muscle relaxants for emergency intubation and surgery
02/13/2001US6187568 Culture product of actinoplane; immunosuppressant, fungicides, antitumor agents
02/13/2001CA2054895C 7-acyl-3-(substituted carbamoyloxy) cephem compounds and process for their preparation
02/07/2001EP1074554A2 7-acyl-3-(substituted carbamoyloxy) cephem compounds, use thereof and process for their preparation
02/07/2001EP1074553A1 7-Acyl-3-(substituted carbamoyloxy) cephem compounds, use thereof and process for their preparation
02/07/2001EP1073658A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
02/07/2001EP1073653A1 Novel 2-heterocyclically substituted dihydropyrimidines
02/07/2001EP1073637A1 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases
02/07/2001CN1283185A New crystalline polymorphic form of 1-methyl-5-p-toluoylpyrroel-2-acetamidoacetic acid guaiacyl ester (MED 15)
02/07/2001CN1282739A Intermediate used in preparing oxdiazine and its manufacturing method
02/07/2001CN1061648C Antiarrhythmic and cardioprotective substituted indenoyiguanidines
02/01/2001WO2001007408A2 Novel method for preparing benzoperhydroisoindole compounds
02/01/2001CA2379859A1 Novel method for preparing benzoperhydroisoindole compounds
01/2001
01/31/2001EP0768884B1 Drugs containing a synergistic mixture of metronidazole and clindamycin
01/31/2001CN1282316A Substituted cyslopentane and cyclopentene compounds useful as neuraminidase inhibitors
01/30/2001US6180635 Novel thieno(2,3-d)pyrimidinediones which exhibit pharmacological activity, in particular immunosuppressive activity; treating allograft rejection
01/25/2001WO2000058293A3 Glucokinase activators
01/24/2001EP1070069A1 Bicyclic hydroxamic acid derivatives
01/24/2001EP1070065A1 Azabicyclic 5ht1 receptor ligands
01/24/2001CN1061046C Process for preparing cephalosporins derivants
01/24/2001CN1061044C Tricyclic 5,6-dihydro-9H-pyrazolo [3,4-C]-1,2,4-triaolo [4,3-alpha] pyridines
01/24/2001CN1061041C Piperidine derivatives
01/23/2001US6177445 Substituted isoquinolines as ultra short acting neuromuscular blockers
01/17/2001EP1068182A1 Process for preparing a protected 4-aminomethyl-pyrrolidin-3-one
01/17/2001CN1280573A Intermediates for preparation of triazoline herbicide and its preparing process
01/17/2001CN1280572A Inhibiting platelet derivative growth factor and/or quinoline and quinowoline compounds of P56lek tyrosinkinase
01/16/2001US6174889 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
01/16/2001US6174883 3-substituted-2-oxindoles derivatives
01/16/2001CA2223404C Novel crystal form of anhydrous 7-(¬1.alpha., 5.alpha., 6.alpha.|-6-amino-3-azabicyclo¬3.1.0|hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, methanesulfonic acid salt
01/11/2001WO2001002403A1 METHOD FOR PREPARING SUBSTITUTED [1,4]DIAZEPINO[6,7,1-hi]INDOL-4-ONES
01/11/2001CA2376707A1 Process for the preparation of substituted ¬1,4|diazepino¬6,7,1-hi|indol-4-ones
01/10/2001EP1066290A1 PYRROLO[1,2-a]PYRAZINE sPLA 2 INHIBITOR
01/10/2001EP1066259A1 Biocidal benzylbiphenyl derivatives
01/10/2001CN1279681A Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist
01/09/2001US6172237 Process for preparing eprosartan
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 105